PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 204 filers reported holding PTC THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $200,869 | -16.0% | 4,939 | 0.0% | 0.03% | -23.7% |
| Q1 2023 | $239,245 | -3.5% | 4,939 | 0.0% | 0.04% | -19.1% |
| Q3 2022 | $248,000 | +3.8% | 4,939 | -23.0% | 0.05% | +27.0% |
| Q1 2022 | $239,000 | -6.3% | 6,413 | 0.0% | 0.04% | -2.6% |
| Q4 2021 | $255,000 | +6.7% | 6,413 | 0.0% | 0.04% | -2.6% |
| Q3 2021 | $239,000 | -11.8% | 6,413 | 0.0% | 0.04% | -11.4% |
| Q2 2021 | $271,000 | -10.9% | 6,413 | 0.0% | 0.04% | -18.5% |
| Q1 2021 | $304,000 | -22.3% | 6,413 | 0.0% | 0.05% | -28.0% |
| Q4 2020 | $391,000 | +30.3% | 6,413 | 0.0% | 0.08% | +13.6% |
| Q3 2020 | $300,000 | -7.7% | 6,413 | 0.0% | 0.07% | -18.5% |
| Q2 2020 | $325,000 | +13.6% | 6,413 | 0.0% | 0.08% | -8.0% |
| Q1 2020 | $286,000 | -7.1% | 6,413 | 0.0% | 0.09% | +15.8% |
| Q4 2019 | $308,000 | +41.9% | 6,413 | 0.0% | 0.08% | +26.7% |
| Q3 2019 | $217,000 | – | 6,413 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |